Prostate cancer survivors benefit from non-vigorous activity, walking
the ONA take:
After prostate cancer diagnosis, at least five hours of non-vigorous activity or 3 hours of walking is positively associated with better hormone and vitality functioning, according to a study published in the Journal of Cancer Survivorship.
Siobhan Phillips, PhD, MPH, at Northwestern University Feinberg School of Medicine and fellow researchers prospectively examined 1,917 men diagnosed with non-metastatic prostate cancer in the Health Professionals Follow-Up Study.
They looked at associations between activity and sedentary behavior after prostate cancer diagnosis in terms of health-related quality of life.
The researchers found that, upon adjusting for confounders, higher duration of non-vigorous and walking activity were associated with higher vitality and hormonal functioning scores.
The effects approached clinical significance for men in the highest versus lowest categories, with survivors who walked at least 90 minutes a week at a normal or faster pace reporting higher scores than men who walked less than 90 minutes a week at an easy pace.
Total activity was found to be associated with higher hormone and vitality functioning in men who were at least five years post-treatment and had more advanced disease.
“Encouraging men to engage in non-vigorous activity and walking may be helpful for managing prostate cancer-related health-related quality of life,” the authors concluded.
After prostate cancer diagnosis, at least five hours of non-vigorous activity or 3 hours of walking is beneficial.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|